Bellerophon Therapeutics

Showing 2 posts of 2 posts found.

Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD

June 6, 2023
Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease

Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …

Bellerophon Therapeutics completes phase 3 study for fibrotic interstitial lung disease drug

May 12, 2023
Medical Communications Bellerophon Therapeutics, Cardiology, clinical trial, lung disease

US clinical stage biotherapeutics company Bellerophon Therapeutics has announced that the last patient has completed its phase 3 REBUILD study, …

Latest content